IMC Chicago’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,268
Closed -$1.23M 5829
2025
Q4
$970K Sell
75,268
-23,074
-23% -$244K ﹤0.01% 2997
2025
Q3
$830K Sell
98,342
-89,469
-48% -$844K ﹤0.01% 2840
2025
Q2
$1.62M Buy
187,811
+14,466
+8% +$107K ﹤0.01% 2158
2025
Q1
$1.5M Buy
+173,345
New +$1.23M ﹤0.01% 1991
2024
Q3
Sell
-20,851
Closed -$192K 2884
2024
Q2
$217K Buy
20,851
+221
+1% +$2.21K ﹤0.01% 2576
2024
Q1
$207K Sell
20,630
-45,910
-69% -$494K ﹤0.01% 2322
2023
Q4
$1.02M Buy
66,540
+43,603
+190% +$602K ﹤0.01% 1432
2023
Q3
$321K Buy
+22,937
New +$347K ﹤0.01% 1517

Other funds holding HLF

IMC Chicago's HLF Position: Q1 2026 in Review

IMC Chicago sold out of Herbalife (HLF) in Q1 2026, closing a stake of 75,268 shares — an estimated $1.23M sold.

IMC Chicago first reported a position in HLF in Q3 2023 and held it in 8 quarters. The position peaked at $1.62M in Q2 2025. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • IMC Chicago reported no remaining Herbalife position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 75,268 Herbalife shares in Q1 2026, an estimated $1.23M.
  • IMC Chicago first reported a position in Herbalife in Q3 2023 and held it in 8 quarters.
  • IMC Chicago's Herbalife position peaked at $1.62M in Q2 2025.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.